1nhaler
PrivateLast Round
Seed
Nov 17, 2025
Total Funding Raised
$4.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
1nhaler is a medical device company that is a developer of a single-dose, disposable, dry-powder inhaler.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
1nhaler Comparables
Compare 1nhaler with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merxin Ltd | 78% | |
| PureIMS | 77% | |
| AptarGroup | 73% | |
1nhaler Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 17, 2025 | ||||
| Seed | Nov 27, 2023 |
1nhaler Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scottish Investment Bank (Scottish Enterprise) | Seed |
| British Business Investments | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
$2M round with British Business Investments and Scottish Investment Bank.
- Nov 27, 2023
$2.5M raised from British Business Investments and Dr Yusuf Hamied.
1nhaler Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 1nhaler's valuation, stock price, and market status.